Specifically, {TAIL ~ the present invention} provides a mutant Herpes Simplex Virus 2 comprising {HEAD ~ a modification} of the ICP10 gene and the use of this mutant HSV 2 for the treatment of malignant diseases 
Specifically , { TAIL ~ the present invention } provides a mutant Herpes Simplex Virus 2 comprising { HEAD ~ a modification } of the ICP10 gene and the use of this mutant HSV 2 for the treatment of malignant diseases
OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH